Friday, June 2, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Action

RALEIGH, N.C. - A shareholder class action claims Cempra Inc. and its executives failed to disclose that an antibiotic it developed to treat bacterial pneumonia and urethritis poses significant health risks to some individuals. The class claims when this information became public, the value of their shares dropped from $18.65 to $7.30 in a single day.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.